Counterfeit or Substandard? Assessing Price and Non-Price Signals of Drug Quality
NBER Working Paper No. 18073
---- Acknowledgements ----
This paper previously circulated under the title "Counterfeit or Substandard? The Role of Regulation and Distribution Channel in Drug Safety." The Legatum Institute funded the collection of medicines and testing and a grant from the Social Sciences and Humanities Research Council of Canada provided subsequent funding to cover analysis of survey results. We would also like to thank Andreas Seiter and other participants at the World Bank seminar for their comments and suggestions. All errors are ours. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.